ArticleBritish journal of cancer2011

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.

J Lehmann-Che et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.